In summary, this study has revealed a novel role of SHBs in the regulation of hepatic gluconeogenesis via activation of cAMP/PKA/CREB signaling, which may provide new mechanistic insight into the possible link between HBV infection and diabetes and may also offer potential preventive and therapeutic targets for glucose metabolism disorder in HBV patients. This evidence concerns the gene CREB1 and glucose metabolism disease.